BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38608546)

  • 1. Quantification of lipoprotein lipase in mouse plasma with a sandwich enzyme-linked immunosorbent assay.
    Kimura T; Miyashita K; Fukamachi I; Fukamachi K; Ogura K; Yokoyama E; Tsunekawa K; Nagasawa T; Ploug M; Yang Y; Song W; Young SG; Beigneux AP; Nakajima K; Murakami M
    J Lipid Res; 2024 Apr; 65(4):100532. PubMed ID: 38608546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes.
    Ikeda Y; Takagi A; Ohkaru Y; Nogi K; Iwanaga T; Kurooka S; Yamamoto A
    J Lipid Res; 1990 Oct; 31(10):1911-24. PubMed ID: 2079612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma.
    Kimura H; Ohkaru Y; Katoh K; Ishii H; Sunahara N; Takagi A; Ikeda Y
    Clin Biochem; 1999 Feb; 32(1):15-23. PubMed ID: 10074887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men.
    Matsumoto R; Tsunekawa K; Shoho Y; Yanagawa Y; Kotajima N; Matsumoto S; Araki O; Kimura T; Nakajima K; Murakami M
    Lipids Health Dis; 2019 Apr; 18(1):84. PubMed ID: 30947712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase.
    Bensadoun A; Mottler CD; Pelletier C; Wu D; Seo JJ; Leung CS; Adeyo O; Goulbourne CN; Gin P; Fong LG; Young SG; Beigneux AP
    Biochim Biophys Acta; 2014 Jul; 1841(7):970-6. PubMed ID: 24681165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.
    Turlo K; Leung CS; Seo JJ; Goulbourne CN; Adeyo O; Gin P; Voss C; Bensadoun A; Fong LG; Young SG; Beigneux AP
    Biochim Biophys Acta; 2014 Jul; 1841(7):963-9. PubMed ID: 24704550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
    Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
    J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.
    Davies BS; Beigneux AP; Barnes RH; Tu Y; Gin P; Weinstein MM; Nobumori C; Nyrén R; Goldberg I; Olivecrona G; Bensadoun A; Young SG; Fong LG
    Cell Metab; 2010 Jul; 12(1):42-52. PubMed ID: 20620994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
    Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a direct sandwich-enzyme-linked immunosorbent assay for the quantification of human hepatic triglyceride lipase mass in human plasma.
    Nishimura M; Ohkaru Y; Ishii H; Sunahara N; Takagi A; Ikeda Y
    J Immunol Methods; 2000 Feb; 235(1-2):41-51. PubMed ID: 10675756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.
    Weinstein MM; Yin L; Beigneux AP; Davies BS; Gin P; Estrada K; Melford K; Bishop JR; Esko JD; Dallinga-Thie GM; Fong LG; Bensadoun A; Young SG
    J Biol Chem; 2008 Dec; 283(50):34511-8. PubMed ID: 18845532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency.
    Nyrén R; Chang CL; Lindström P; Barmina A; Vorrsjö E; Ali Y; Juntti-Berggren L; Bensadoun A; Young SG; Olivecrona T; Olivecrona G
    BMC Physiol; 2012 Nov; 12():14. PubMed ID: 23186339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.
    Hu X; Sleeman MW; Miyashita K; Linton MF; Allan CM; He C; Larsson M; Tu Y; Sandoval NP; Jung RS; Mapar A; Machida T; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
    J Lipid Res; 2017 Jan; 58(1):208-215. PubMed ID: 27875259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing.
    Song W; Beigneux AP; Weston TA; Chen K; Yang Y; Nguyen LP; Guagliardo P; Jung H; Tran AP; Tu Y; Tran C; Birrane G; Miyashita K; Nakajima K; Murakami M; Tontonoz P; Jiang H; Ploug M; Fong LG; Young SG
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2313825120. PubMed ID: 37871217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.
    Shetty SK; Walzem RL; Davies BSJ
    J Lipid Res; 2020 Apr; 61(4):546-559. PubMed ID: 32029511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(5):e96482. PubMed ID: 24788417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
    Yang Y; Beigneux AP; Song W; Nguyen LP; Jung H; Tu Y; Weston TA; Tran CM; Xie K; Yu RG; Tran AP; Miyashita K; Nakajima K; Murakami M; Chen YQ; Zhen EY; Kim JR; Kim PH; Birrane G; Tontonoz P; Ploug M; Konrad RJ; Fong LG; Young SG
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated hepatic LPL expression ameliorates severe hypertriglyceridemia and acute pancreatitis in Gpihbp1 deficient mice and rats.
    Yuan C; Xu Y; Lu G; Hu Y; Mao W; Ke L; Tong Z; Xia Y; Ma S; Dong X; Xian X; Wu X; Liu G; Li B; Li W
    Mol Ther; 2024 Jan; 32(1):59-73. PubMed ID: 37974401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.